Kaspar Rufibach
Biostatistician, Merck Group With over 20 years of experience in biostatistics, Kaspar is a dedicated mathematical statistician with a strong theoretical foundation, honed through various roles in the biostatistical field and combines a deep understanding of statistical theory.
About this speaker
Kaspar is an Expert Statistical Scientist in Roche’s Methods, Collaboration, and Outreach group and is located in Basel.
He does methodological research, provides consulting to Roche statisticians and broader project teams, gives biostatistics training for statisticians and non-statisticians in- and externally, mentors students, and interacts with external partners in industry, regulatory agencies, and the academic community in various working groups and collaborations.
He has co-founded and co-leads the European special interest group “Estimands in oncology” (sponsored by PSI and EFSPI, which also has the status as an ASA scientific working group, a subsection of the ASA biopharmaceutical section) that currently has 39 members representing 23 companies, 3 continents, and several Health Authorities. The group works on various topics around estimands in oncology.
Kaspar’s research interests are methods to optimize study designs, advanced survival analysis, probability of success, estimands, and causal inference, estimation of treatment effects in subgroups, and general nonparametric statistics. Before joining Roche, Kaspar received training and worked as a statistician at the Universities of Bern, Stanford, and Zurich.
More on the oncology estimand WG: http://www.oncoestimand.org
More on Kaspar: http://www.kasparrufibach.ch
